Edwin Emilio Valdivia Malqui

Mr. Edwin Emilio Valdivia Malqui

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in International Journal of Immunogenetics
Verified
Journal Article
Open access
PDF file
MCMarco Carvalho‐Oliveira
Marco Carvalho‐Oliveira
EMEdwin Emilio Valdivia Malqui
Edwin Emilio Valdivia Malqui
RBRainer Blasczyk
Rainer Blasczyk
Constança FigueiredoConstança Figueiredo
Constança Figueiredo
Xenotransplantation may become the highly desired solution to close the gap between the availability of donated organs and number of patients on the waiting list. In recent years, enormous progress has been made in the development of genetically engineered donor pigs. The introduced genetic modifications showed to be efficient in prolonging xenograft survival. In this review, we focus on the type of immune responses that may target xeno‐organs after transplantation and promising immunogenetic modifications that show a beneficial effect in ameliorating or eliminating harmful xenogeneic immune responses. Increasing histocompatibility of xenografts by eliminating genetic discrepancies between species will pave their way into clinical application.

19 April 2022 in Human Gene Therapy
Verified
Journal Article
Closed access
EMEdwin Emilio Valdivia Malqui
Edwin Emilio Valdivia Malqui
TRTamina Rother
Tamina Rother
YYYuliia Yuzefovych
Yuliia Yuzefovych
FHFranziska Hack
Franziska Hack
NWNadine Wenzel
Nadine Wenzel
CFConstanca Figueiredo
Constanca Figueiredo
Genetic engineering is a promising tool to repair genetic disorders, improve graft function, or reduce immune responses toward allografts. Ex vivo organ perfusion systems have the potential to mitigate ischemic-reperfusion injury, prolong preservation time, or even rescue organ function. We aim at combining both technologies to develop a modular platform allowing the genetic modification of vascularized composite (VC) allografts. Rat hind limbs were perfused ex vivo under subnormothermic conditions with lentiviral vectors. Specific perfusion conditions such as controlled pressure, temperature, and flow rates were optimized to support the genetic modification of the limbs. Genetic modification was detected in vascular, muscular, and dermal limb tissues. Remarkably, skin follicular and interfollicular keratinocytes, as well as endothelial cells showed stable transgene expression. Furthermore, levels of injury markers such as lactate, myoglobin, and lactate dehydrogenase, as well as histological analyses showed that ex vivo limb perfusion with lentiviral vectors did not cause tissue damage and limb cytokine secretion signatures were not significantly affected. The use of ex vivo VC perfusion in combination with lentiviral vectors allows an efficient and stable genetic modification representing a robust platform to genetically engineer limbs toward increasing graft survival after transplantation.

Verified
Journal Article
Open access
PDF file
KSKatharina Schmalkuche
Katharina Schmalkuche
RSReinhard Schwinzer
Reinhard Schwinzer
NWNadine Wenzel
Nadine Wenzel
EMEdwin Emilio Valdivia Malqui
Edwin Emilio Valdivia Malqui
Bjoern PetersenBjoern Petersen
Bjoern Petersen
Constança FigueiredoConstança Figueiredo
Constança Figueiredo
Xenotransplantation reemerged as a promising alternative to conventional transplantation enlarging the available organ pool. However, success of xenotransplantation depends on the design and selection of specific genetic modifications and on the development of robust assays allowing for a precise assessment of tissue-specific immune responses. Nevertheless, cell-based assays are often compromised by low proliferative capacity of primary cells. Proximal tubular epithelial cells (PTECs) play a crucial role in kidney function. Here, we generated immortalized PTECs (imPTECs) by overexpression of simian virus 40 T large antigen. ImPTECs not only showed typical morphology and phenotype, but, in contrast to primary PTECs, they maintained steady cell cycling rates and functionality. Furthermore, swine leukocyte antigen (SLA) class I and class II transcript levels were reduced by up to 85% after transduction with lentiviral vectors encoding for short hairpin RNAs targeting β2-microglobulin and the class II transactivator. This contributed to reducing xenogeneic T-cell cytotoxicity (p < 0.01) and decreasing secretion of pro-inflammatory cytokines such as IL-6 and IFN-γ. This study showed the feasibility of generating highly proliferative PTECs and the development of tissue-specific immunomonitoring assays. Silencing SLA expression on PTECs was demonstrated to be an effective strategy to prevent xenogeneic cellular immune responses and may strongly support graft survival after xenotransplantation.

18 February 2026 in Nature Protocols
Verified
Journal Article
Closed access
FSFawaz Saleh
Fawaz Saleh
EMEdwin Emilio Valdivia Malqui
Edwin Emilio Valdivia Malqui
IGIngrid Gensch
Ingrid Gensch
Maximilian SchinkeMaximilian Schinke
Maximilian Schinke
MKMalene Kappelhøj
Malene Kappelhøj
NLNico Lachmann
Nico Lachmann